VitaNova Life Sciences (VNOV) Debt Ratio (2017 - 2025)

VitaNova Life Sciences has reported Debt Ratio for 7 years, with the latest figure at 0.08 in Q1 2025.

• For the quarter ending Q1 2025, Debt Ratio rose 71.66% year-over-year to 0.08; the trailing twelve-month figure through Jan 2025 stood at 0.08 (up 71.66% YoY), and the FY2024 full-year result was 0.0, down 99.86% from the prior year.
• Debt Ratio for Q1 2025 stood at 0.08, down from 0.1 in the prior quarter.
• The five-year high for Debt Ratio was 1.84 in Q2 2023, with the low at 0.0 in Q2 2024.
• Historically, Debt Ratio has averaged 0.46 across 5 years, with a median of 0.31 in 2022.
• Annual changes were most pronounced in 2023 — Debt Ratio soared 411.18% — and 2024, when it plunged 99.86%.
• VitaNova Life Sciences' Debt Ratio stood at 0.38 in 2021, then slipped by 9.94% to 0.34 in 2022, then soared by 436.47% to 1.84 in 2023, then tumbled by 94.49% to 0.1 in 2024, then decreased by 24.07% to 0.08 in 2025.
• The last three Debt Ratio figures came in at 0.08 (Q1 2025), 0.1 (Q4 2024), and 0.05 (Q3 2024), per Business Quant data.